 |
 |

Clinical Features in Early Parkinson Disease and Survival
Raymond Y. Lo, MD;
Caroline M. Tanner, MD, PhD;
Kathleen B. Albers, MPH;
Amethyst D. Leimpeter, MSc;
Robin D. Fross, MD;
Allan L. Bernstein, MD;
Valerie McGuire, PhD;
Charles P. Quesenberry, PhD;
Lorene M. Nelson, PhD;
Stephen K. Van Den Eeden, PhD
Arch Neurol. 2009;66(11):1353-1358.
Objective To examine the association between demographic and clinical features in early Parkinson disease (PD) and length of survival in a multiethnic population.
Design Clinical features within 2 years of diagnosis were determined for an inception cohort established during 1994-1995. Vital status was determined through December 31, 2005. Predictor variables included age at diagnosis, sex, race/ethnicity, as well as clinical subtype (modified tremor dominant, postural instability gait difficulty), symmetry, cognitive impairment, depression, dysphagia, and hallucinations. Cox proportional hazards regression analysis was used to identify factors associated with shorter survival.
Setting Kaiser Permanente Medical Care Program, northern California.
Patients Five hundred seventy-three men and women with newly diagnosed PD.
Results Three hundred fifty-two participants in the PD cohort (61.4%) had died in the follow-up period. Older age at diagnosis (hazard ratio [HR], 1.1; 95% confidence interval [CI], 1.09-1.12), modified postural instability gait difficulty subtype (HR, 1.8; 95% CI, 1.3-2.7), symmetry of motor signs (HR, 2.0; 95% CI, 1.1-3.7), mild (HR, 1.7; 95% CI, 1.3-2.2) and severe (HR, 2.7; 95% CI, 1.9-3.9) cognitive impairment, dysphagia (HR, 1.4; 95% CI, 1.1-1.9), and hallucinations (HR, 2.1; 95% CI, 1.3-3.2) were associated with increased all-cause mortality, after adjusting for age, sex, and race/ethnicity. None of the other factors altered mortality risk. In an empirical predictive analysis, most previous significant predictors remained associated with shorter survival.
Conclusions Both motor and nonmotor features in early PD predict increased mortality risk, particularly postural instability gait difficulty, cognitive impairment, and hallucinations. These predictors may be useful in clinical practice and when designing clinical trials.
Author Affiliations: The Parkinson's Institute and Clinical Center, Sunnyvale, California (Drs Lo and Tanner); Division of Research, Kaiser Permanente, Oakland, California (Mss Albers and Leimpeter and Drs Quesenberry and Van Den Eeden); Department of Neurology, Kaiser Hayward Medical Center, Hayward, California (Dr Fross); Department of Neurology, Kaiser Santa Rosa Medical Center, Santa Rosa, California (Dr Bernstein); and Department of Health Research and Policy, Stanford University, Stanford, California (Drs McGuire and Nelson).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
RELATED ARTICLE
This Month in Archives of Neurology
Arch Neurol. 2009;66(11):1320-1321.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Role of the Musculoskeletal System and the Prevention of Falls
Fraix
J Am Osteopath Assoc 2012;112:17-21.
ABSTRACT
| FULL TEXT
Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease
Ramlackhansingh et al.
Neurology 2011;76:1811-1816.
ABSTRACT
| FULL TEXT
What predicts mortality in Parkinson disease?: A prospective population-based long-term study
Forsaa et al.
Neurology 2010;75:1270-1276.
ABSTRACT
| FULL TEXT
|